Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD save search
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.98%
H: 0.73%
C: -1.19%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.49%
H: 0.72%
C: -0.36%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 2.61%
H: 20.19%
C: 14.8%
acquisition therapy
Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein
Published: 2022-07-06 (Crawled : 13:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.0%
H: 27.62%
C: 14.36%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.72%
H: 0.41%
C: 0.18%
covid-19 treatment lenzilumab publication
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
ACLX | $51.67 -5.19% -5.48% 740K
|
|
| O: 20.66%
H: 9.21%
C: 7.11%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
collaboration
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
Published: 2021-03-18 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 0.08%
H: 9.84%
C: 6.32%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.24%
H: 2.14%
C: 0.72%
financial results results
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.11%
H: 0.39%
C: 0.06%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.46%
H: 1.46%
C: 1.15%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.16%
H: 1.21%
C: 0.95%
SUPN | $29.43 1.94% 1.9% 360K
|
Health Technology
|
| O: -0.32%
H: 5.23%
C: 4.43%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.41%
OTIC | $0.077
|
Health Technology
|
| O: -1.88%
H: 2.3%
C: 0.0%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: -1.44%
H: 3.5%
C: 2.24%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.67%
H: 0.15%
C: -1.22%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -0.72%
H: 1.06%
C: 0.76%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: -4.08%
H: 7.03%
C: 6.04%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.64%
H: 0.2%
C: -0.32%
HOOKIPA Pharma to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: -0.4%
H: 6.8%
C: 6.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.27%
H: 2.44%
C: 2.21%
financial results results pharma
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-09 (Crawled : 21:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 0.51%
H: 7.28%
C: 5.3%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.0%
H: 0.71%
C: -0.47%
financial results results bioscience
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common Stock
Published: 2021-03-10 (Crawled : 04:00) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -5.07%
H: 6.86%
C: 4.81%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.54%
H: 0.19%
C: -1.19%
offering
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Published: 2021-08-26 (Crawled : 00:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.17%
H: 1.6%
C: -0.04%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 0.65%
H: 5.79%
C: 4.5%
merge bioscience
Galapagos announces full year 2022 results and outlook for 2023
Published: 2023-02-23 (Crawled : 22:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.33%
H: 0.04%
C: -1.96%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -7.42%
H: 5.64%
C: 4.06%
year
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Published: 2021-01-06 (Crawled : 17:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.5%
H: 3.98%
C: 3.77%
therapy collaboration cancer blood ford research solid tumors
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study
Published: 2022-08-15 (Crawled : 16:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.41%
H: 3.83%
C: 3.7%
cs-02 trodelvy cancer study her2- her2 metastatic breast cancer
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
Published: 2022-08-15 (Crawled : 01:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.41%
H: 3.83%
C: 3.7%
trodelvy acquire
The Galien Foundation Debuts 2021 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology" and "Best Digital Health Solution" Categories
Published: 2021-07-20 (Crawled : 14:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.83%
H: 0.53%
C: -0.06%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.23%
H: 0.87%
C: 0.31%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
GKOS | $96.5 1.44% 0.0% 700K
|
Health Technology
|
| O: -10.48%
H: 0.13%
C: -4.92%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.37%
H: 1.17%
C: 0.01%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.22%
H: 4.07%
C: 3.56%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.11%
H: 1.89%
C: 0.43%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.29%
H: 1.02%
C: 0.78%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.52%
H: 0.92%
C: -0.18%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.22%
H: 3.66%
C: 3.66%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 0.13%
H: 2.21%
C: -0.39%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.13%
H: 2.12%
C: 1.23%
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 0.25%
H: 3.02%
C: 2.77%
biotech technology iot
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 2.21%
H: 5.29%
C: 3.62%
therapy research
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
Published: 2023-06-08 (Crawled : 22:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.41%
H: 0.68%
C: 0.64%
PGEN | $1.33 0.76% 0.75% 1M
|
Health Technology
|
| O: 0.0%
H: 0.76%
C: -4.55%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.63%
H: 1.87%
C: -1.25%
ITOS | $10.58 2.42% 2.36% 940K
|
Health Technology
|
| O: -0.52%
H: 3.23%
C: -2.2%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.42%
H: 3.56%
C: 3.48%
cancer
Galapagos announces first quarter 2023 financial results
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.29%
H: 1.37%
C: 1.27%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 2.86%
H: 3.14%
C: 2.95%
financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.